Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000644117 | SCV000765807 | likely benign | Tuberous sclerosis 2 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001022882 | SCV001184669 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-08-09 | criteria provided, single submitter | clinical testing | The p.A1560T variant (also known as c.4678G>A), located in coding exon 36 of the TSC2 gene, results from a G to A substitution at nucleotide position 4678. The alanine at codon 1560 is replaced by threonine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV001766382 | SCV002001062 | uncertain significance | not provided | 2024-03-06 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 18466115, 38256219) |
Institute for Clinical Genetics, |
RCV001766382 | SCV002011327 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000644117 | SCV002040216 | uncertain significance | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003153784 | SCV003843801 | likely pathogenic | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004003996 | SCV004843594 | uncertain significance | Tuberous sclerosis syndrome | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004568427 | SCV005054454 | uncertain significance | Isolated focal cortical dysplasia type II | 2024-02-29 | criteria provided, single submitter | clinical testing |